Amgen

$228.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.99 (-0.43%) Today
+$0.07 (+0.03%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Amgen and other stocks, options, and ETFs commission-free!

About AMGN

Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. The listed name for AMGN is Amgen Inc. Common Stock.

Employees
23,400
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
133.53B
Price-Earnings Ratio
18.89
Dividend Yield
2.70
Average Volume
3.05M
High Today
$229.93
Low Today
$226.17
Open Price
$228.01
Volume
2.17M
52 Week High
$264.97
52 Week Low
$177.05

Collections

AMGN Earnings

$0.00
$1.42
$2.83
$4.25
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$3.80 per share
Actual
Available Oct 28, After Hours

You May Also Like